Short-term efficacy and safety of neoadjuvant pyrotinib plus taxanes for early HER2-positive breast cancer: a single-arm exploratory phase II trial
新辅助吡咯替尼联合紫杉烷类药物治疗早期 HER2 阳性乳腺癌的短期疗效和安全性:一项单臂探索性 II 期试验
期刊:Gland Surgery
影响因子:1.6
doi:10.21037/gs-24-38
Ye, Guolin; Chen, Peixian; Liu, Xiangwei; He, Tiancheng; Pivot, Xavier; Pan, Ruilin; Zhou, Dan; Zhu, Lewei; Zhang, Kun; Li, Wei; Yang, Shuqing; Lin, Jiawei; Cai, Gengxi; Huang, Huiqi